arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

enVVeno Medical Corp

NVNO
$7.05 ▼ -0.01 (-0.14%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
40 Visible periods
21 Metrics
Peer-ranked Benchmarks
Price Chart
24
Health
Poor
Bearish
auto_awesome

Analytical Summary

enVVeno Medical Corp faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $4.9M
Dividend Yield —
Revenue Growth None
Op. Margin —
ROIC -21.2% ↘
FCF / Share $-4.58 ↗
Trailing P/E —
Price / Book 0.3x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

40-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$0.00
— —
Net Income Profit after all expenses
$-4.37M
↑ +3.8% —
FCF / Share Free cash flow per share
$-4.58
↑ +13.4% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓
12
Cash Quality ↑
54

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 10 years · 40 quarters